Home › program initiates
 

Keywords :   


Tag: program initiates

Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide,...

2013-01-25 02:36:38| Biotech - Topix.net

Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials evaluating a single tablet regimen containing tenofovir alafenamide for the treatment of HIV-1 infection in treatment-nai 1 2ve adults.

Tags: program phase clinical initiates

 

Gilead Initiates Phase 3 Clinical Program For Tenofovir Alafenamide, A Novel Low-Dose Prodrug For The Treatment Of HIV

2013-01-24 09:30:00| drugdiscoveryonline News Articles

Gilead Sciences, Inc. recently announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults

Tags: the of program treatment

 

Sites : [1] [2]